Uptake of Melatonin into the Cerebrospinal Fluid After Nasal and Intravenous Delivery: Studies in Rats and Comparison with a Human Study

[1]  P. Merkus,et al.  Hydroxocobalamin Uptake into the Cerebrospinal Fluid after Nasal and Intravenous Delivery in Rats and Humans , 2003, Journal of drug targeting.

[2]  H. Guchelaar,et al.  Direct access of drugs to the human brain after intranasal drug administration? , 2003, Neurology.

[3]  Mandip Singh,et al.  Effect of vehicles on the transdermal delivery of melatonin across porcine skin in vitro. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[4]  F. Merkus,et al.  Serial cerebrospinal fluid sampling in a rat model to study drug uptake from the nasal cavity , 2002, Journal of Neuroscience Methods.

[5]  F. Merkus,et al.  Uptake of hydrocortisone into the cerebrospinal fluid of rats: comparison of intranasal and intravenous administration in the same animal , 2002 .

[6]  B. Jansson,et al.  Levels of dopamine in blood and brain following nasal administration to rats. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[7]  W. Frey,et al.  Intranasal administration of insulin-like growth factor-I bypasses the blood–brain barrier and protects against focal cerebral ischemic damage , 2001, Journal of the Neurological Sciences.

[8]  J. Born,et al.  Time Course of Intranasally Administered Cholecystokinin-8 on Central Nervous Effects , 2001, Neuropsychobiology.

[9]  H. Guchelaar,et al.  Quantitative determination of melatonin in human plasma and cerebrospinal fluid with high-performance liquid chromatography and fluorescence detection. , 2000, Biomedical chromatography : BMC.

[10]  L. Illum.  Transport of drugs from the nasal cavity to the central nervous system. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[11]  Temsamani,et al.  Brain drug delivery technologies: novel approaches for transporting therapeutics. , 2000, Pharmaceutical science & technology today.

[12]  E. Björk,et al.  Nasal absorption of (S)-UH-301 and its transport into the cerebrospinal fluid of rats. , 2000, International journal of pharmaceutics.

[13]  D. T. John,et al.  A LIGHT MICROSCOPY STUDY OF THE MIGRATION OF NAEGLERIA FOWLERI FROM THE NASAL SUBMUCOSA TO THE CENTRAL NERVOUS SYSTEM DURING THE EARLY STAGE OF PRIMARY AMEBIC MENINGOENCEPHALITIS IN MICE , 2000, The Journal of parasitology.

[14]  J. Born,et al.  Brain Potentials and Attention after Acute and Subchronic Intranasal Administration of ACTH 4–10 and Desacetyl-α-MSH in Humans , 1999, Neuroendocrinology.

[15]  J. Henriksson,et al.  Uptake of metals in the brain via olfactory pathways. , 1999, Neurotoxicology.

[16]  J. Born,et al.  Central nervous system effects of intranasally administered insulin during euglycemia in men. , 1999, Diabetes.

[17]  J. Born,et al.  Intranasal angiotensin II directly influences central nervous regulation of blood pressure. , 1998, American journal of hypertension.

[18]  M. Saneyoshi,et al.  Direct transport of 2',3'-didehydro-3'-deoxythymidine (D4T) and its ester derivatives to the cerebrospinal fluid via the nasal mucous membrane in rats. , 1998, Biological & pharmaceutical bulletin.

[19]  U. Kompella,et al.  Nasal route for direct delivery of solutes to the central nervous system: fact or fiction? , 1998, Journal of drug targeting.

[20]  K. Chou,et al.  Distribution of antihistamines into the CSF following intranasal delivery. , 1997, Biopharmaceutics & drug disposition.

[21]  S. Yamashita,et al.  Direct drug transport from the nasal cavity to the cerebrospinal fluid. A new strategy for drug delivery to the brain , 1997 .

[22]  J. Born,et al.  A nose-brain pathway for psychotropic peptides: evidence from a brain evoked potential study with cholecystokinin , 1996, Psychoneuroendocrinology.

[23]  J. Born,et al.  Brain potential changes after intranasal vs. intravenous administration of vasopressin: evidence for a direct nose-brain pathway for peptide effects in humans , 1996, Biological Psychiatry.

[24]  T. Seki,et al.  Nasal absorption of zidovudine and its transport to cerebrospinal fluid in rats. , 1994, Biological & pharmaceutical bulletin.

[25]  D. Jm.  The relevance to humans of animal models for inhalation studies of cancer in the nose and upper airways. , 1993 .

[26]  J. DeSesso.  The relevance to humans of animal models for inhalation studies of cancer in the nose and upper airways. , 1993, Quality assurance.

[27]  W. Rascher,et al.  Involvement of adrenergic and angiotensinergic receptors in the paraventricular nucleus in the angiotensin II-induced vasopressin release. , 1992, The Journal of pharmacology and experimental therapeutics.

[28]  T. Unger,et al.  Angiotensin II-induced noradrenaline release from anterior hypothalamus in conscious rats: a brain microdialysis study , 1991, Brain Research.

[29]  M. Hashida,et al.  Transport of cephalexin to the cerebrospinal fluid directly from the nasal cavity , 1991, The Journal of pharmacy and pharmacology.

[30]  E. Bechgaard,et al.  Intranasal administration of insulin to humans. , 1991, Diabetes research and clinical practice.

[31]  M. Hussain,et al.  Nasal administration of a cognition enhancer provides improved bioavailability but not enhanced brain delivery. , 1990, Journal of pharmaceutical sciences.

[32]  Anand Kumar Tc,et al.  Uptake of radioactivity by body fluids and tissues in rhesus monkeys after intravenous injection or intranasal spray of tritium-labelled oestradiol and progesterone. , 1974 .

[33]  R. Duma,et al.  Experimental naegleria meningoencephalitis in mice. Penetration of the olfactory mucosal epithelium by Naegleria and pathologic changes produced: a light and electron microscope study. , 1973, Laboratory investigation; a journal of technical methods and pathology.